Home Midwest Cleveland, OH Neuronoff, Inc COMPANY
Clinical Phase 1
Also known as Neuronoff · 3 sources
Location: Cleveland, OH · source · Oct 14, 2026
Profile checked Oct 10, 2026
Keywords: Chronic Lower Limb Pain Chronic Pain Lower Back Pain Chronic hypertension heart failure Neuronoff BASMATI Injectrode PNS Injectrode F1 Show all 7 keywords
At a glance HQ Cleveland, OH source Region Midwest Stage Clinical Phase 1 Latest trial Phase 1: Lumbar Injectrode Feasibility Evaluation (Jan 12, 2024) source Timeline Jan 12, 2024 Trial start Phase 1: Lumbar Injectrode Feasibility Evaluation source ↗ Dec 4, 2020 Trial start Not phased (device or behavioral study): Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode source ↗ Clinical trials (lead sponsor) 2 Record Title Phase Status Start Primary completion NCT04672096 Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode Not phased (device or behavioral study) Completed Dec 4, 2020 May 21, 2021 (actual) NCT06206356 Lumbar Injectrode Feasibility Evaluation Phase 1 Completed Jan 12, 2024 Mar 15, 2024 (actual)
NIH awards 1 Annual award amounts. Total $597K.
Jul 25, 2023 NIH award 1R43HL169127-01 FY2023: $596,582 awarded for that fiscal year; activity R43 (SBIR); PI FRANKE, MANFRED; recipient as written: NEURONOFF, INC., Cleveland, OH. The Injectrode- An injectable, easily removable source ↗ 